PH-dependent and Carrier-mediated Transport of Salicylic Acid Across Caco-2 Cells
Overview
Pharmacy
Authors
Affiliations
The transport of monocarboxylic acid drugs such as salicylic acid was examined in the human colon adenocarcinoma cell line, Caco-2 cells that possess intestinal epithelia-like properties. [14C]Salicylic acid transport was pH-dependent and appeared to follow the pH-partition hypothesis. However, 10 mM unlabelled salicylic acid significantly reduced the permeability coefficient of [14C]salicylic acid. Kinetic analysis of the concentration dependence of the permeation rate of salicylic acid across Caco-2 cells showed both saturable (Kt = 5.28 +/- 0.72 mM Jmax = 36.6 +/- 3.54 nmol min-1 (mg protein)-1) and nonsaturable (kd = 0.37 +/- 0.08 microL min-1 (mg protein)-1) processes. The permeation rate of [14C]salicylic acid was competitively inhibited by both acetic acid and benzoic acid, which were demonstrated in our previous studies to be transported in the carrier-mediated-transport mechanism which is responsible for monocarboxylic acids. Furthermore, certain monocarboxylic acids significantly inhibited [14C]salicylic acid transport, whereas salicylamide and dicarboxylic acids such as succinic acid did not. From these results, it was concluded that the transcellular transport of [14C]salicylic acid across Caco-2 cells is by the pH-dependent and carrier-mediated transport mechanism specific for monocarboxylic acids.
Neumaier F, Zlatopolskiy B, Neumaier B Pharmaceutics. 2021; 13(10).
PMID: 34683835 PMC: 8538549. DOI: 10.3390/pharmaceutics13101542.
Rybenkov V, Zgurskaya H, Ganguly C, Leus I, Zhang Z, Moniruzzaman M Chem Rev. 2021; 121(9):5597-5631.
PMID: 33596653 PMC: 8369882. DOI: 10.1021/acs.chemrev.0c01137.
Intra and Extracellular Journey of the Phytohormone Salicylic Acid.
Maruri-Lopez I, Aviles-Baltazar N, Buchala A, Serrano M Front Plant Sci. 2019; 10:423.
PMID: 31057566 PMC: 6477076. DOI: 10.3389/fpls.2019.00423.
Lee N, Kang Y Pharm Res. 2016; 33(7):1711-22.
PMID: 27026010 DOI: 10.1007/s11095-016-1912-6.
Quantitation of small intestinal permeability during normal human drug absorption.
Levitt D BMC Pharmacol Toxicol. 2013; 14:34.
PMID: 23800230 PMC: 3734790. DOI: 10.1186/2050-6511-14-34.